Business
Johnson & Johnson pauses COVID-19 vaccine trial after participant experiences unexplained illness – ABC News
Johnson & Johnson temporarily pauses one of the highest-profile efforts to contain the global COVID-19 pandemic while it reviews an illness in a vaccine trial p…
Johnson & Johnson says it has temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness in a study participant, delaying one of the highest-profile efforts to contain the global pandemic.
Key points:
- The participant in J&J’s trial is being reviewed and evaluated by an independent monitor
- It follows AstraZeneca’s pause of its vaccine trial, which has since been resumed in the UK, Brazil, South Africa and India
- J&J has sai…
Continue Reading
